Wintac, Ltd. is an affiliate of Somerset Therapeutics that produces vials, ampoules, and ophthalmic products. The company has been USFDA-compliant since 2013 and was most recently audited by the agency in 2019.
Wintac has been in operation since 1987. The company develops and manufactures drug product from its 120,000 sq ft facility with 70,000 sq ft of sterile operations area. The company has also been audited by the Australian, French, and Kenyan regulatory authorities.